Your browser doesn't support javascript.
loading
PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652.
Liu, Yuncheng; Peng, Yuan; Du, Wei; Yu, Chunyu; Peng, Zijun; Qin, Leyi; Ma, Yilei; Wu, Xin; Peng, Yani; Cheng, Xiao; Xia, Lu; Fa, Hangwei; Wu, Yuqing; Sun, Luyang; Liu, Jianying; Liu, Zhihua; Shang, Yongfeng; Wang, Shu; Liang, Jing.
Affiliation
  • Liu Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Peng Y; Breast Disease Center, Peking University People's Hospital, Beijing 100044, China.
  • Du W; Breast Disease Center, Peking University People's Hospital, Beijing 100044, China.
  • Yu C; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 311121, China.
  • Peng Z; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Qin L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Ma Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Wu X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Peng Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Cheng X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Xia L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Fa H; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Wu Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Sun L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China.
  • Liu J; Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
  • Liu Z; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Shang Y; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China; Department of Biochemistry and Molecular Biology, School of Basic M
  • Wang S; Breast Disease Center, Peking University People's Hospital, Beijing 100044, China. Electronic address: wangshu@pkuph.edu.cn.
  • Liang J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China. Electronic address: liang_jing@hsc.pku.edu.cn.
Cell Rep ; 42(11): 113343, 2023 11 28.
Article in En | MEDLINE | ID: mdl-37906592
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: China Country of publication: United States